 REDWOOD CITY, Calif., Sept. 07, 2021 GLOBE NEWSWIRE -- Rezolute, Inc. Nasdaq: RZLT, a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, today announced that Nevan Charles Elam, CEO and Founder, will present at two upcoming virtual investment conferences. 